Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting ...

There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its fourth-quarter sales guidance by 5%.Please watch the video at Investors.com - ...

Intuitive Surgical stock broke out Wednesday after the robotic surgery giant crushed views in its preliminary fourth-quarter report.

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus's ...

The company will protect the branded anti-interleukin (IL)-12/23 biologic against sales erosion from pending biosimilars.

Emulsifiers — found in many packaged foods such as candy, salad dressings, and baked goods — have been linked to bodily ...

NLRP3 Inhibitor Portfolio: Ventyx is advancing a portfolio of potential best-in-class oral NLRP3 inhibitors for systemic inflammatory conditions and neurodegenerative diseases, including VTX2735, a ...

AbbVie and Simcere Zaiming have announced a partnership worth over $1bn to develop an investigational drug candidate for ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 503.77% and ...

A loss-of-function mutation to the PTPN2 gene, commonly associated with autoimmune diseases, can make cells more susceptible ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ability to invade human cells. SARS-CoV-2 is the virus that spreads COVID-19.

Aaron Kinsey and Juliette Reeves discuss research on the oral microbiome which is informing a more holistic approach to ...